TipRanks
Contineum Therapeutics, Inc. Class A (CTNM)
NASDAQ:CTNM
US Market
CTNM
Contineum Therapeutics, Inc. Class A
RESEARCH TOOLSreports
Want to see CTNM full AI Analyst Report?

Contineum Therapeutics, Inc. Class A (CTNM) Balance Sheet

226 Followers

Contineum Therapeutics, Inc. Class A Balance Sheet

Contineum Therapeutics, Inc. Class A's total assets for Q2 2026 were $250.37M, a decrease of -4.20% from the previous quarter. CTNM total liabilities were $10.71M for the fiscal quarter, a -5.31% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
$ 276.64M$ 212.85M$ 130.39M$ 50.64M$ 70.52M
Total Liabilities
$ 15.65M$ 14.78M$ 198.32M$ 11.37M$ 8.93M
Total Equity Gross Minority
$ 260.99M$ 198.07M$ -67.94M$ 39.27M$ 61.59M
Other Metrics
Currency in USD

Contineum Therapeutics, Inc. Class A Debt to Assets